RT @spektrum@twitter.com

Es ist das derzeit teuerste Medikament der Welt: Eine einmalige Behandlung mit dem Präparat #Hemgenix reicht aus, um die #Bluterkrankheit #Hämophilie B zu therapieren. Die #EMA hat nun die bedingte Zulassung für die #Gentherapie erteilt. https://www.spektrum.de/news/haemophilie-das-3-5-millionen-dollar-medikament/2091675?utm_term=Autofeed&utm_medium=Social&utm_source=Twitter#Echobox=1671542100

🐦🔗: https://twitter.com/spektrum/status/1605233407939809281

A tip for the inquisitive journalist
The take away from #FDA's approval of #Hemgenix - a #genetherapy for #hæmophiliaB - has been that Hemgenix is now the most expensive drug in the world, because manufacturer #CSLBehring priced the treatment at 3.5 million $ after it was approved
via #theguardian
https://bit.ly/3tVt0NJ
But what about focusing on how that price tag was calculated?
Andf if #CSLBehring are following a trend seen with other new drugs for chronic conditions 1/

#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B

#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.

#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.

#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b

The good news is, the FDA has approved #Hemgenix, an apparently effective treatment for #hemophiliaB - which is characterized by a lack of the clotting factor IX
The not-so-good news is that manufacturer #CSLBehring, after approval, has priced the treatment - a #genetherapy - at $3.5 million a dose, making it the most expensive drug in the world
via @guardian
https://bit.ly/3tVt0NJ